ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,740, issued on Aug. 11, was assigned to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seoul, South Korea).
"GKN1 (gastrokine 1) specific antibody, and use thereof" was invented by Won Sang Park (Seoul, South Korea) and Jung Hwan Yoon (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel antibody specifically binding to a specific epitope of GKN1 (gastrokine 1) protein, and a gastric cancer diagnostic use thereof. An antibody specific to GKN1 according to the present invention specifically binds to a new epitope, and can be used to confirm the level of GKN1 protein in ...